\
&
Contact us
This was 1 year ago
LocationOnline
ProgrammesAENEAS, EPoSS, and INSIDE organise an online Networking Event for Competence Centres Applicants.
Competence Centres in semiconductors are essential to the Chips for Europe Initiative, offering critical technical expertise and training, especially for SMEs to improve their design skills. These centres will support stakeholders along the electronic components and systems value chain, including start-ups and SMEs, by providing essential services and guidance. They will facilitate the use of capacities and facilities, including the design platform and pilot lines, and support stakeholders in developing semiconductor solutions through technology transfer. Additionally, they will address skills shortages by offering training, including workforce upskilling and reskilling. The centres match user needs with expertise within their network and serve as an access point. They also promote the Chips Fund and facilitate access to venture capital, raising awareness, promoting services, and highlighting success stories.
The Chips JU calls for 2024 on Competence Centres opened on 4 July 2024. Key calls include Chips-2024-CCC-1 for selecting designated Competence Centres and Chips-2024-CCC-2 for building a network of these centres, enhancing collaboration across Europe. The deadline for both calls is 2 October 2024.
This workshop specifically addresses representatives of future Competence Centers that have been selected by their national public authorities. This event will offer unique opportunities for participants to:
More information on the open calls can be found on the dedicated website of the Chips JU. To register for the event, please use this link.
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.